These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 14587432)

  • 1. [Mydocalm causing anaphylaxis].
    Kwaśniewski A; Korbuszewska-Gontarz B; Mika S
    Pneumonol Alergol Pol; 2003; 71(5-6):250-2. PubMed ID: 14587432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anaphylactic reactions to tolperisone (Mydocalm).
    Ribi C; Vermeulen C; Hauser C
    Swiss Med Wkly; 2003 Jun; 133(25-26):369-71. PubMed ID: 12947534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An immediate hypersensitivity reaction caused by tolperisone hydrochloride.
    Glück J; Rymarczyk B; Rogala B
    J Investig Allergol Clin Immunol; 2011; 21(5):411-2. PubMed ID: 21905508
    [No Abstract]   [Full Text] [Related]  

  • 4. Results of the post-registration clinical study "PARUS" on efficiency and safety assessment of Mydocalm-Richter for local injection therapy of a myofascial trigger zone.
    Devlikamova FI
    Ter Arkh; 2018 Jun; 90(6):81-88. PubMed ID: 30701909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of sedative effects of single and repeated doses of 50 mg and 150 mg tolperisone hydrochloride. Results of a prospective, randomized, double-blind, placebo-controlled trial.
    Dulin J; Kovács L; Ramm S; Horvath F; Ebeling L; Kohnen R
    Pharmacopsychiatry; 1998 Jul; 31(4):137-42. PubMed ID: 9754848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Evaluation of efficacy and safety of mydocalm in the early rehabilitation of stroke].
    Kovalchuk VV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2013; 113(4):35-40. PubMed ID: 23739438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The results of the multicenter pharmaco-epidemiological observational project on the use of mydocalm in the treatment of pain syndromes with the muscle spasm].
    Skoromets AA; Guekht AB; Galanov DV; Danilenko OA; Barantsevich ER; Lebedeva AV; Belova AN; Shprakh VV; Bogdanov EI; Prokopenko SV; Khabirov FA; Spirin NN; Baliazin VA; Miakotnykh VS; Volkova LI; Gafurov BG; Mishchenko TS; Toktomushev CT; Shyralieva RK; Musaev SK; Guseinov SG
    Zh Nevrol Psikhiatr Im S S Korsakova; 2015; 115(12):104-109. PubMed ID: 26978502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Anaphylactic type of accidents due to myorelaxing agents during general anesthesia. Clinical and biological study].
    Vervloet D; Arnaud A; Vellieux P; Kaplanski S; Charpin J
    Nouv Presse Med; 1977 Mar; 6(9):725-8. PubMed ID: 66668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Several years observations with Mydocalm muscle relaxant in locomotor disease patients.
    Gálos G
    Ther Hung; 1992; 40(2):69-71. PubMed ID: 1462278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Anaphylactic shock leading to death in a young woman after oral administration of metamizole (Pyralginum-Polfa)--case report].
    Jaszczuk E; Graczyk M; Oszukowski P; Brzeziński P
    Przegl Lek; 1999; 56(2):175-6. PubMed ID: 10375955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effectiveness and safety of tolperisone in spasticity following cerebral stroke: randomized, double-blind, placebo-controlled trial].
    Lipták J
    Ideggyogy Sz; 2013 Jul; 66(7-8):283-4. PubMed ID: 23971362
    [No Abstract]   [Full Text] [Related]  

  • 12. [Efficiency local injection therapy with preparation mydocalm in myofascial pain syndrome cervicobrachial region].
    Shirokov VA; Iun OP; Bakhtereva EV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2009; 109(6):78-80. PubMed ID: 19688873
    [No Abstract]   [Full Text] [Related]  

  • 13. [A clinical efficacy of electrode pharmaphoresis in treatment of railway workers with low-back pain].
    Popov VV; Menenkova EY; Babakhina SN; Bezzubik EG; Isakova YA; Lezina DS; Dmukhovski DV; Merkulov YA; Merkulova DM
    Zh Nevrol Psikhiatr Im S S Korsakova; 2015; 115(12):118-122. PubMed ID: 26978504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Case of an allergic reaftion to mydocalm].
    Aleksandrov IuS; Danilov LN
    Klin Med (Mosk); 1974 Apr; 52(4):142. PubMed ID: 4459560
    [No Abstract]   [Full Text] [Related]  

  • 15. [To make easier everyday life of stroke patients. Muscle relaxants diminish spasms].
    MMW Fortschr Med; 2003 Feb; 145(9):57. PubMed ID: 12666538
    [No Abstract]   [Full Text] [Related]  

  • 16. [The administration of mydocalm and donalgin in vertebro-radicular syndromes].
    Ovanesian GA; Martirosian GP
    Zh Nevrol Psikhiatr Im S S Korsakova; 1999; 99(11):47-8. PubMed ID: 10578538
    [No Abstract]   [Full Text] [Related]  

  • 17. Efficacy and tolerance of repeated oral doses of tolperisone hydrochloride in the treatment of painful reflex muscle spasm: results of a prospective placebo-controlled double-blind trial.
    Pratzel HG; Alken RG; Ramm S
    Pain; 1996 Oct; 67(2-3):417-25. PubMed ID: 8951937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anaphylactic reaction to oral prednisone: a case report and review of the literature.
    Polosa R; Cacciola R; Pacino G; Prosperini G
    Ann Ital Med Int; 1998; 13(1):47-52. PubMed ID: 9642842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Anaphylactic shock after diclofenac sodium (Voltaren)].
    Hadar A; Holcberg G; Mazor M
    Harefuah; 2000 Feb; 138(3):211-2, 270. PubMed ID: 10883095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Reasons for the use of mydocalm in the prevention and treatment of antibiotic-induced sensorineural hearing loss].
    Lantsov AA; Anichin VF; Alibekov IM
    Vestn Otorinolaringol; 1989; (5):15-20. PubMed ID: 2588406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.